Long-term outcome following thulium vaporesection of the prostate

Abstract

ThuVaRP is both an effective and safe treatment procedure for symptomatic BPO (with a low occurrence of complications). Lasers Surg. Med. 48:505-510, 2016. © 2016 Wiley Periodicals, Inc.

Thulium Vaporesection of the Prostate and Thulium Vapoenucleation of the Prostate: A Retrospective Bicentric Matched-Paired Comparison with 24-Month Follow-Up

“…In this series, voiding parameters (Qmax, PVR) and symptom scores (IPSS, QoL) were significantly improved after ThuVEP and ThuVaRP at 12- and 24-month follow-up, in line with the current HoLEP [2, 3, 7], PVP [2, 3], and TURP [2-4, 6, 9, 11, 15, 22, 23] literature and well-comparable to former ThuVEP [7, 8, 17, 18] and ­ThuVaRP [4, 6, 9-14, 22, 24-26] series. However, at 24-month follow-up, Qmax and PVR were significantly different between ThuVEP and ThuVaRP, while no differences were found between the groups with regard to IPSS and QoL.…”

“…In accordance with the low Hb decrease, the rate of postoperative blood transfusions was low and not different between both groups (1.3%) and in line with the HoLEP [2, 3], PVP [2, 3], ThuVaRP [4, 6, 9-14, 22-26], and ThuVEP [7, 8, 16-18] literature. One explanation for the differences in Hb decrease in our series might be a larger surface of the pseudocapsule of the prostate after ThuVEP compared to ThuVaRP.…”

“…Due to the retrospective non-randomized approach, a selection bias based on primary detrusor failure due to long-lasting BPO in the ThuVEP group cannot be excluded completely, since pressure flow studies have not been performed preoperatively. Although significant differences in Qmax and PVR were found in our study, the clinical relevance is questionable, since the Qmax and PVR values in our series at 12- and 24-month follow-up after ThuVEP are well comparable with the TURP [2-4, 6, 9, 11, 15, 22, 23], HoLEP [2, 3], PVP [2, 3], ThuVaRP [4, 6, 9-14, 22, 24-26] and ThuVEP [7, 8, 17, 18] literature.…”

“…These RR are similar to HoLEP [2, 3, 27], TURP [2, 3, 27], PVP [2, 3, 27], and ThuVEP [8, 17, 24] series. RR ranging from 1.3 to 2.1% for bladder neck contractures [12, 13, 24], from 2.1 to 3.5% for urethral strictures [11-13, 25, 26] and from 1.2 to 2.6% for regrowth of prostatic tissue [12, 14] have been reported for ThuVaRP at 24-month follow-up. Due to lesser tissue removal with the ThuVaRP procedure in our study, one would expect a higher RR for regrowth of prostatic tissue with a longer follow-up.…”

Thulium laser vaporesection of the prostate: Can we operate without interrupting oral antiplatelet/anticoagulant therapy?

“…Fu et al [5] reported one case of urethral stricture and no cases of bladder neck contracture in their study. In a recent study by Yu et al [27], the authors reported a UTI rate of 10%. In our study, 4 of 47 patients in group A (8.5%) and 7 of 56 patients in group B (12.5%) had UTI.…”